Why the study?
Particularly after major surgery, the risk of early pharmacological venous thromboembolism prophylaxis must be balanced against the risk of postoperative bleeding.
What are the guideline recommendations for perioperative venous thromboembolism prophylaxis in cardiovascular surgery?
Population
Patients undergoing cardiac or vascular surgery
Comparison
Pharmacological VTE prophylaxis strategies
Design
Clinical practice guideline with systematic literature review
Authors
Loading...
Early pharmacologic prophylaxis after CABG cuts VTE without excess bleeding; confirms net benefit and challenges delayed-start practice.
Systematic Review
What are the guideline recommendations for perioperative venous thromboembolism prophylaxis in cardiovascular surgery?
Relative Risk: 0.44 (95% CI 0.28–0.71)
p-value: p=<0.01
These European guidelines recommend early pharmacological VTE prophylaxis, preferably with low molecular weight heparin, for patients undergoing cardiac and high-risk vascular surgery.
Ahmed et al. (2024) conducted a systematic review in Venous thromboembolism in cardiovascular surgery. Early pharmacological VTE prophylaxis vs. Delayed or no prophylaxis was evaluated on Symptomatic VTE (RR 0.44, 95% CI 0.28-0.71, p=<0.01). Early administration of pharmacological venous thrombosis prophylaxis in cardiac surgery significantly reduces the risk of symptomatic VTE (RR 0.44; 95% CI 0.28-0.71; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: